Cargando…

Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy

Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and cardiac fibrosis. Emerging evidence indicated that endothelial-to-mesenchymal transition (Endo-MT) is a crucial event during organ fibrosis. This study was performed to clarify whether Endo-MT contributed to the progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yeqing, Liao, Jianquan, Yu, Yong, Guo, Qi, Yang, Yingzhen, Ge, Junbo, Chen, Haozhu, Chen, Ruizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780177/
https://www.ncbi.nlm.nih.gov/pubmed/29115553
http://dx.doi.org/10.3892/mmr.2017.8013
_version_ 1783294698442457088
author Xie, Yeqing
Liao, Jianquan
Yu, Yong
Guo, Qi
Yang, Yingzhen
Ge, Junbo
Chen, Haozhu
Chen, Ruizhen
author_facet Xie, Yeqing
Liao, Jianquan
Yu, Yong
Guo, Qi
Yang, Yingzhen
Ge, Junbo
Chen, Haozhu
Chen, Ruizhen
author_sort Xie, Yeqing
collection PubMed
description Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and cardiac fibrosis. Emerging evidence indicated that endothelial-to-mesenchymal transition (Endo-MT) is a crucial event during organ fibrosis. This study was performed to clarify whether Endo-MT contributed to the progression of cardiac fibrosis in DCM. Cardiac samples from patients with DCM and control were obtained. The presence of endothelial markers, cluster of differentiation (CD)31 and vascular endothelial (VE)-cadherin, and mesenchymal markers, α smooth muscle actin (SMA) and fibroblast-specific protein 1 (FSP1) was performed using immunohistochemistry. Co-localization of endothelial markers and mesenchymal markers were identified using confocal immunofluorescence staining. Serum procollagen type I carboxy-terminal propeptide (PICP) and procollagen type III amino-terminal propeptide (PIIINP) were measured by ELISA. Protein levels of Wnt, β-catenin and Snail were determined using western blot analysis. Immunohistochemistry and double-immunofluorescence staining demonstrated that the expression of CD31 and VE-cadherin were significantly decreased in DCM samples, whereas the FSP-1, and αSMA were significantly increased. CD31 and VE-cadherin labeling indexes were respectively negatively correlated with left ventricular end-diastolic diameter (LVEDD) (CD31 r=−0.82, P<0.01; VE-cadherin r=−0.73, P<0.01), while FSP-1 and αSMA were positively associated with LVEDD (αSMA r=0.65, P<0.01, FSP1 r=0.53, P<0.01) and left ventricular ejection fraction (αSMA r=−0.18, P<0.05; FSP1 r=−0.21, P<0.05). Furthermore, PICP and PIIINP levels were positively associated with the co-expression labeling indexes (CD31/SMA co-labeling index and PICP r=0.727, P<0.01; CD31/SMA co-labeling index and PIIINP r=0.741, P<0.01; VE-Cadherin/FSP-1 co-labeling index and PICP r=0.716, P<0.01; VE-cadherin/FSP-1 co-labeling index and PIIINP r=0.648, P<0.05). Western blot analysis indicated that proteins levels of Wnt signaling and snail were significantly increased in DCM samples. These results suggested that Endo-MT is potentially implicated in the pathogenesis of myocardial fibrosis and remodeling during the development of DCM, indicating a potential therapeutic target for DCM treatment.
format Online
Article
Text
id pubmed-5780177
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57801772018-02-05 Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy Xie, Yeqing Liao, Jianquan Yu, Yong Guo, Qi Yang, Yingzhen Ge, Junbo Chen, Haozhu Chen, Ruizhen Mol Med Rep Articles Dilated cardiomyopathy (DCM) is characterized by left ventricular dilation and cardiac fibrosis. Emerging evidence indicated that endothelial-to-mesenchymal transition (Endo-MT) is a crucial event during organ fibrosis. This study was performed to clarify whether Endo-MT contributed to the progression of cardiac fibrosis in DCM. Cardiac samples from patients with DCM and control were obtained. The presence of endothelial markers, cluster of differentiation (CD)31 and vascular endothelial (VE)-cadherin, and mesenchymal markers, α smooth muscle actin (SMA) and fibroblast-specific protein 1 (FSP1) was performed using immunohistochemistry. Co-localization of endothelial markers and mesenchymal markers were identified using confocal immunofluorescence staining. Serum procollagen type I carboxy-terminal propeptide (PICP) and procollagen type III amino-terminal propeptide (PIIINP) were measured by ELISA. Protein levels of Wnt, β-catenin and Snail were determined using western blot analysis. Immunohistochemistry and double-immunofluorescence staining demonstrated that the expression of CD31 and VE-cadherin were significantly decreased in DCM samples, whereas the FSP-1, and αSMA were significantly increased. CD31 and VE-cadherin labeling indexes were respectively negatively correlated with left ventricular end-diastolic diameter (LVEDD) (CD31 r=−0.82, P<0.01; VE-cadherin r=−0.73, P<0.01), while FSP-1 and αSMA were positively associated with LVEDD (αSMA r=0.65, P<0.01, FSP1 r=0.53, P<0.01) and left ventricular ejection fraction (αSMA r=−0.18, P<0.05; FSP1 r=−0.21, P<0.05). Furthermore, PICP and PIIINP levels were positively associated with the co-expression labeling indexes (CD31/SMA co-labeling index and PICP r=0.727, P<0.01; CD31/SMA co-labeling index and PIIINP r=0.741, P<0.01; VE-Cadherin/FSP-1 co-labeling index and PICP r=0.716, P<0.01; VE-cadherin/FSP-1 co-labeling index and PIIINP r=0.648, P<0.05). Western blot analysis indicated that proteins levels of Wnt signaling and snail were significantly increased in DCM samples. These results suggested that Endo-MT is potentially implicated in the pathogenesis of myocardial fibrosis and remodeling during the development of DCM, indicating a potential therapeutic target for DCM treatment. D.A. Spandidos 2018-01 2017-11-08 /pmc/articles/PMC5780177/ /pubmed/29115553 http://dx.doi.org/10.3892/mmr.2017.8013 Text en Copyright: © Xie et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Xie, Yeqing
Liao, Jianquan
Yu, Yong
Guo, Qi
Yang, Yingzhen
Ge, Junbo
Chen, Haozhu
Chen, Ruizhen
Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
title Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
title_full Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
title_fullStr Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
title_full_unstemmed Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
title_short Endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
title_sort endothelial-to-mesenchymal transition in human idiopathic dilated cardiomyopathy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780177/
https://www.ncbi.nlm.nih.gov/pubmed/29115553
http://dx.doi.org/10.3892/mmr.2017.8013
work_keys_str_mv AT xieyeqing endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT liaojianquan endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT yuyong endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT guoqi endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT yangyingzhen endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT gejunbo endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT chenhaozhu endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy
AT chenruizhen endothelialtomesenchymaltransitioninhumanidiopathicdilatedcardiomyopathy